LQDA
Price
$18.14
Change
+$0.12 (+0.67%)
Updated
Jun 6 closing price
Capitalization
1.54B
60 days until earnings call
ROIV
Price
$11.23
Change
+$0.03 (+0.27%)
Updated
Jun 6 closing price
Capitalization
7.61B
71 days until earnings call
Interact to see
Advertisement

LQDA vs ROIV

Header iconLQDA vs ROIV Comparison
Open Charts LQDA vs ROIVBanner chart's image
Liquidia
Price$18.14
Change+$0.12 (+0.67%)
Volume$1.35M
Capitalization1.54B
Roivant Sciences
Price$11.23
Change+$0.03 (+0.27%)
Volume$4.93M
Capitalization7.61B
LQDA vs ROIV Comparison Chart
Loading...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LQDA vs. ROIV commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LQDA is a StrongBuy and ROIV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (LQDA: $14.18 vs. ROIV: $10.62)
Brand notoriety: LQDA and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LQDA: 158% vs. ROIV: 100%
Market capitalization -- LQDA: $1.54B vs. ROIV: $7.61B
LQDA [@Biotechnology] is valued at $1.54B. ROIV’s [@Biotechnology] market capitalization is $7.61B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LQDA’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • LQDA’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, LQDA is a better buy in the long-term than ROIV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LQDA’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 4 bullish TA indicator(s).

  • LQDA’s TA Score: 4 bullish, 6 bearish.
  • ROIV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than LQDA.

Price Growth

LQDA (@Biotechnology) experienced а -14.92% price change this week, while ROIV (@Biotechnology) price change was -2.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

LQDA is expected to report earnings on Aug 07, 2025.

ROIV is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($7.61B) has a higher market cap than LQDA($1.54B). LQDA YTD gains are higher at: 20.536 vs. ROIV (-10.228). ROIV has higher annual earnings (EBITDA): 4.1B vs. LQDA (-115.71M). ROIV has more cash in the bank: 5.15B vs. LQDA (176M). ROIV has less debt than LQDA: ROIV (100M) vs LQDA (122M). ROIV has higher revenues than LQDA: ROIV (123M) vs LQDA (14M).
LQDAROIVLQDA / ROIV
Capitalization1.54B7.61B20%
EBITDA-115.71M4.1B-3%
Gain YTD20.536-10.228-201%
P/E RatioN/A1.97-
Revenue14M123M11%
Total Cash176M5.15B3%
Total Debt122M100M122%
FUNDAMENTALS RATINGS
LQDA: Fundamental Ratings
LQDA
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
39
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LQDAROIV
RSI
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 12 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
90%
Bullish Trend 12 days ago
63%
Momentum
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 12 days ago
73%
MACD
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 12 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
84%
Bearish Trend 12 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
86%
Bearish Trend 12 days ago
70%
Advances
ODDS (%)
Bullish Trend 25 days ago
85%
Bullish Trend 20 days ago
71%
Declines
ODDS (%)
Bearish Trend 18 days ago
84%
Bearish Trend 12 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
81%
N/A
Aroon
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 12 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

LQDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LQDA has been loosely correlated with MTVA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LQDA jumps, then MTVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LQDA
1D Price
Change %
LQDA100%
-9.13%
MTVA - LQDA
44%
Loosely correlated
-5.08%
XERS - LQDA
29%
Poorly correlated
-1.04%
ROIV - LQDA
29%
Poorly correlated
-1.30%
ELVN - LQDA
29%
Poorly correlated
+0.50%
FOLD - LQDA
27%
Poorly correlated
-2.24%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-1.30%
IMVT - ROIV
61%
Loosely correlated
-1.33%
ACLX - ROIV
53%
Loosely correlated
-1.29%
CRNX - ROIV
53%
Loosely correlated
+1.39%
KYMR - ROIV
52%
Loosely correlated
+2.35%
KRYS - ROIV
50%
Loosely correlated
-2.44%
More